|
AnaptysBio, Inc. (ANAB) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
AnaptysBio, Inc. (ANAB) Bundle
Enhance your investment choices with the AnaptysBio, Inc. (ANAB) DCF Calculator! Explore authentic AnaptysBio financials, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of AnaptysBio, Inc. (ANAB).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.0 | 75.0 | 63.2 | 10.3 | 17.2 | 20.0 | 23.4 | 27.4 | 32.0 | 37.3 |
| Revenue Growth, % | 0 | 837.5 | -15.77 | -83.72 | 66.78 | 16.82 | 16.82 | 16.82 | 16.82 | 16.82 |
| EBITDA | -95.9 | -19.4 | -55.7 | -105.3 | -143.2 | -16.6 | -19.4 | -22.7 | -26.5 | -30.9 |
| EBITDA, % | -1199.16 | -25.83 | -88.18 | -1023.2 | -834.43 | -82.8 | -82.8 | -82.8 | -82.8 | -82.8 |
| Depreciation | .5 | .6 | 2.1 | 2.3 | 2.4 | 1.9 | 2.2 | 2.6 | 3.0 | 3.5 |
| Depreciation, % | 6.42 | 0.74533 | 3.31 | 22.7 | 13.85 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 |
| EBIT | -96.4 | -19.9 | -57.8 | -107.6 | -145.5 | -16.8 | -19.6 | -22.9 | -26.7 | -31.2 |
| EBIT, % | -1205.59 | -26.57 | -91.49 | -1045.9 | -848.28 | -83.61 | -83.61 | -83.61 | -83.61 | -83.61 |
| Total Cash | 374.2 | 393.7 | 548.1 | 441.2 | 390.9 | 20.0 | 23.4 | 27.4 | 32.0 | 37.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .9 | 1.4 | 6.9 | 2.2 | 2.6 | 3.0 | 3.5 | 4.1 |
| Account Receivables, % | 0 | 0 | 1.39 | 13.79 | 39.93 | 11.02 | 11.02 | 11.02 | 11.02 | 11.02 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0.000001582905 | 0.000009721007 | 0 | 0.000002260782 | 0.000002260782 | 0.000002260782 | 0.000002260782 | 0.000002260782 |
| Accounts Payable | 16.2 | 4.2 | 1.7 | 2.8 | 4.7 | 6.5 | 7.6 | 8.9 | 10.4 | 12.2 |
| Accounts Payable, % | 202.96 | 5.62 | 2.76 | 27.06 | 27.38 | 32.56 | 32.56 | 32.56 | 32.56 | 32.56 |
| Capital Expenditure | -.8 | -.6 | -1.4 | -.4 | -.8 | -.8 | -1.0 | -1.2 | -1.4 | -1.6 |
| Capital Expenditure, % | -10.06 | -0.75867 | -2.16 | -3.48 | -4.7 | -4.23 | -4.23 | -4.23 | -4.23 | -4.23 |
| Tax Rate, % | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 | 0.00244464 |
| EBITAT | -96.3 | -19.9 | -57.2 | -107.6 | -145.5 | -16.7 | -19.5 | -22.8 | -26.7 | -31.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -80.4 | -32.0 | -59.8 | -105.1 | -147.5 | -9.2 | -17.6 | -20.6 | -24.0 | -28.0 |
| WACC, % | 10.03 | 10.03 | 9.98 | 10.04 | 10.04 | 10.02 | 10.02 | 10.02 | 10.02 | 10.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -72.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -29 | |||||||||
| Terminal Value | -357 | |||||||||
| Present Terminal Value | -221 | |||||||||
| Enterprise Value | -293 | |||||||||
| Net Debt | -18 | |||||||||
| Equity Value | -275 | |||||||||
| Diluted Shares Outstanding, MM | 27 | |||||||||
| Equity Value Per Share | -10.22 |
What You Will Get
- Pre-Filled Financial Model: AnaptysBio’s actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
- Instant Calculations: Automatic updates ensure you see results as you make changes.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.
Key Features
- 🔍 Real-Life ANAB Financials: Pre-filled historical and projected data for AnaptysBio, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate AnaptysBio’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize AnaptysBio’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based ANAB DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically refresh to display AnaptysBio’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial assessment.
Why Choose This Calculator for AnaptysBio, Inc. (ANAB)?
- Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for AnaptysBio.
- Customizable Inputs: Modify yellow-highlighted fields to explore different financial scenarios for (ANAB).
- Detailed Insights: Automatically computes AnaptysBio’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and consultants focusing on (ANAB).
Who Should Use AnaptysBio, Inc. (ANAB)?
- Biotech Students: Explore drug development processes and apply theoretical knowledge to real-world scenarios.
- Researchers: Utilize cutting-edge models for innovative studies in immunology and drug discovery.
- Investors: Evaluate your investment strategies and analyze market performance for AnaptysBio stock.
- Industry Analysts: Enhance your analysis with a customizable framework for assessing biotech companies.
- Healthcare Professionals: Understand how biotech firms like AnaptysBio are evaluated and the impact on patient care.
What the Template Contains
- Preloaded ANAB Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.